Chiron/Gen-Probe Procleix HIV/HCV NAT Test To Cost $10-15 Per Screen
This article was originally published in The Gray Sheet
Executive Summary
FDA is preparing to release a draft guidance on nucleic acid test (NAT) screening of whole blood samples following approval of Chiron and Gen-Probe's Procleix HIV-1/HCV NAT assay on Feb. 28